Oncodesign Precision Medicine S.A | Investor Relations

About Oncodesign Precision Medicine S.A

Company Description

OPM is a technological company specialized in precision medicine.

OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.

For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.

Year founded

2020

Served area

Worldwide

Headquarters

18 rue Jean Mazen, 21000 Dijon – France

Filings & Publications

Insider Trades

Contact Investor Relations department

Email address

First name

Last name

Phone number

Company

Your message

Yes, I have read, understand and agree to the Privacy Policy

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.

Oncodesign Precision Medicine S.A Claim profile